Liesbeth Dekking

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans	2023	Chelsea McLean Karin Dijkman Auguste Gaddah Babajide Keshinro Michael Katwere Macaya Douoguih Cynthia Robinson Laura Solforosi Dominika N. Czapska-Casey Liesbeth Dekking
+ PDF Chat	Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels	2022	Machteld M. Tiemessen Laura Solforosi Liesbeth Dekking Dominika N. Czapska-Casey Jan Serroyen Nancy J. Sullivan Ariane Volkmann Maria Grazia Pau Benoît Callendret Hanneke Schuitemaker
+ PDF Chat	SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques	2021	Ramon Roozendaal Laura Solforosi Daniel J. Stieh Jan Serroyen Roel Straetemans Anna Dari Muriel Boulton Frank Wegmann Sietske K. Rosendahl Huber Joan E. M. van der Lubbe
+	SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques	2021	Ramon Roozendaal Laura Solforosi Daniel J. Stieh Jan Serroyen Roel Straetemans Frank Wegmann Sietske K. Rosendahl Huber Joan E. M. van der Lubbe Jenny Hendriks Mathieu Le Gars

Common Coauthors

Coauthor	Papers Together
Laura Solforosi	4
Dominika N. Czapska-Casey	4
Roland Zahn	4
Ramon Roozendaal	4
Hanneke Schuitemaker	4
Jenny Hendriks	3
Jan Serroyen	3
Jerry Sadoff	3
Sietske K. Rosendahl Huber	2
Mathieu Le Gars	2
Noe B. Mercado	2
Benoît Callendret	2
Roel Straetemans	2
Sarah Janssen	2
Núria Guimerà	2
Jingyou Yu	2
Dan H. Barouch	2
Ariane Volkmann	2
Wouter Koudstaal	2
Kerstin Lühn	2
Abishek Chandrashekar	2
Maria Grazia Pau	2
Daniel J. Stieh	2
Joan E. M. van der Lubbe	2
Frank Wegmann	2
Sarah M. Tete	2
Chelsea McLean	1
Babajide Keshinro	1
Nancy J. Sullivan	1
Cynthia Robinson	1
Michael Katwere	1
Juan José Pérez Ruixo	1
Muriel Boulton	1
Auguste Gaddah	1
Macaya Douoguih	1
Machteld M. Tiemessen	1
Anna Dari	1
Yvonne Wollmann	1
Karin Dijkman	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Correlates of protection against SARS-CoV-2 in rhesus macaques	2020	Katherine McMahan Jingyou Yu Noe B. Mercado Carolin Loos Lisa H. Tostanoski Abishek Chandrashekar Jinyan Liu Lauren Peter Caroline Atyeo Alex Zhu	2
+ PDF Chat	Fitting Linear Mixed-Effects Models Using<b>lme4</b>	2015	Douglas M. Bates Martin Mächler Benjamin M. Bolker Steve Walker	1
+ PDF Chat	Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling	2010	Philippe Jacqmin Lynn McFadyen Janet R. Wade	1
+	Bias reduction of maximum likelihood estimates	1993	David Firth	1
+ PDF Chat	Reemerging Sudan Ebola Virus Disease in Uganda, 2011	2012	Trevor Shoemaker Adam MacNeil Stephen Balinandi Shelley Campbell Joseph Francis Wamala Laura K. McMullan R. G. Downing Julius J. Lutwama Edward Mbidde Ute Ströher	1
+ PDF Chat	Ebola Virus Infection Associated with Transmission from Survivors	2018	Saskia den Boon Barbara J. Marston Tolbert Nyenswah Amara Jambai Moumié Barry Sakoba Keïta Kara Durski Schabbethai S. Senesie Devin Perkins Anita Shah	1
+ PDF Chat	Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection	2019	Andrea Menicucci Allen Jankeel Heinz Feldmann Andrea Marzi Ilhem Messaoudi	1
+ PDF Chat	Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins	2020	Till Koch Monika Rottstegge Paula Ruibal Sergio Gómez‐Medina Emily V. Nelson Beatriz Escudero-Pérez Matthias Pillny My Linh Ly Fara Raymond Koundouno Joseph Akoi Boré	1
+ PDF Chat	Seasonal coronavirus protective immunity is short-lasting	2020	Arthur W. D. Edridge Joanna Kaczorowska Alexis C. R. Hoste Margreet Bakker Michelle Klein Katherine Loens Maarten F. Jebbink Amy Matser Cormac M. Kinsella Paloma Rueda	1
+ PDF Chat	Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response	2020	Ashish Goyal E. Fabián Cardozo-Ojeda Joshua T. Schiffer	1
+ PDF Chat	Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection	2021	David S. Khoury Deborah Cromer Arnold Reynaldi Timothy E. Schlub Adam K. Wheatley Jennifer A. Juno Kanta Subbarao Stephen J. Kent James A. Triccas Miles P. Davenport	1
+ PDF Chat	Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks	2021	Alpha Kabinet Keïta Fara Raymond Koundouno Martin Faye Ariane Düx Julia Hinzmann Haby Diallo Ahidjo Ayouba Frédéric Le Marcis Barré Soropogui Kékoura Ifono	1
+ PDF Chat	Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease	2021	Andrea Marzi Allen Jankeel Andrea Menicucci Julie Callison Kyle L. O’Donnell Friederike Feldmann Amanda N. Pinski Patrick W. Hanley Ilhem Messaoudi	1
+ PDF Chat	Ebola virus disease	2020	Shevin T. Jacob Ian Crozier William A. Fischer Angela Hewlett Colleen S. Kraft Marc-Antoine de La Vega Moses J Soka Victoria Wahl‐Jensen Anthony Griffiths Laura Bollinger	1
+ PDF Chat	Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial	2015	Ana María Henao-Restrepo Ira M. Longini Matthias Egger Natalie E. Dean W. John Edmunds Anton Camacho Miles W. Carroll Moussa Doumbia Bertrand Draguez Sophie Duraffour	1
+ PDF Chat	Randomized Trial of Vaccines for Zaire Ebola Virus Disease	2022	Mark Kieh Laura Richert Abdoul Habib Béavogui Birgit Grund Bailah Leigh Éric D’Ortenzio Seydou Doumbia Edouard Lhomme Samba O. Sow Renaud Vatrinet	1